Discovering new drugs is both our profession and our passion.

Ecrins Therapeutics is a privately held biotech company specialized in the discovery and development of innovative oncology drugs. Our main drug candidate ET-D5 is being developped for human and veterinary oncology applications and is currently in the regulatory preclinical phase. Our other R&D programs are in the discovery phase.

About us

Who we are: our history, our team, our advisors
and our partners

R&D programs

Our Mission : to develop innovative therapies that bring new hope to patients.

Investors

Discover why investing in Ecrins Therapeutics is a great opportunity for you

News

Find our most recent news
right here

Contact us

Have a question? Looking for information?
Please, contact us.

Products & Services for R&D

Need to outsource steps of your project?
Discover what we can do for you.

Welcome to Ecrins Therapeutics

But why “Ecrins”?
Our work is like a long trek to a summit, in which teamwork and perserverence are the keys to reaching our goals.
The Ecrins national park is a gorgeous part of the French Alps in which each hike is a fantastique adventure in front of amazing landscapes. At Ecrins Therapeutics, we have the unique opportunity to work in Grenoble, a city at the foot of the Alps mountain range. None of us is insenstive to the beauty that surrounds us, especially our CEO and cofounder Andrei POPOV who enjoys hiking and rock climbing in the Ecrins National Park.